Khan et al identified risk groups for patients undergoing renal replacement therapy. A patient at higher risk may benefit from more aggressive management or treatment with a novel therapy. The authors are from the University of Aberdeen, Aberdeen Royal Infirmary and Ninewells Hospital in Dundee.

To read more or access our algorithms and calculators, please log in or register.